Caribou Shares Fall After Plans to Evaluate Strategic Alternatives, Discontinue CAR-T Programs
MT newswire2026/10/07 14:1610:16 AM EDT, 10/07/2026 (MT Newswires) -- Caribou Biosciences (CRBU) shares fell more than 49% in Wednesday trading after the company said Tuesday it will evaluate strategic alternatives to maximize stockholder value and discontinue development of its vispa-cel and CB-011 allogeneic CAR-T programs. The company said its board approved a process that could include a merger, acquisition, business combination or other strategic transaction involving Caribou or its assets. Caribou said it also plans to implement a substantial workforce reduction, which is expected to be mostly completed in Q4. Price: 0.58, Change: -0.56, Percent Change: -49.34
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
Crypto prices
More
